The use of thermoregulatory catheters (TRCs) in critically ill patients has become increasingly popular. TRCs have been shown to be effective in regulating patient body temperature with improved outcomes. Critically ill patients, especially multitrauma patients and those with femoral catheters, are at high risk for deep vein thrombosis (DVT). Among patients for whom chemical DVT prophylaxis is not an option, inferior vena cava (IVC) filters are often placed prophylactically. The development of intravascular ultrasound (IVUS) has allowed placement of IVC filters at the bedside for patients who are too ill for transport to the operating room or cardiac catheterization lab. After encountering several patients with occult DVT of the IVC during bedside IVC filter placement, we performed a retrospective review to determine the incidence of DVT or pulmonary embolus (PE) in patients who had been treated with a TRC at Baylor University Medical Center at Dallas. Since 2008, IVC filters have been deployed at the bedside with the use of IVUS at Baylor University Medical Center. During that same time period, 83 patients had a TRC placed for either intravascular warming or cooling during their resuscitation. Forty-seven out of 83 patients who had a TRC placed survived their injuries. Ten of 47 patients (21%) were diagnosed with DVT or PE, and 6 of these 10 (60%) were found to have caval thrombus. We present this case series as evidence that undiagnosed IVC thrombus associated with TRCs may be higher than previously suspected, given that 5 out of 10 patients who had IVUS of their IVC for prophylactic IVC filter placement, as well as one patient diagnosed with PE, were found to have caval thrombus. W ithin the last 15 years, the use of thermoregulatory catheters (TRCs) has gained popularity. Th ey have been used to induce hypothermia to improve outcomes in cases of cardiopulmonary arrest and to reverse the harmful eff ects of hypothermia in the trauma patient by providing a means for rapid rewarming (1) (2) (3) . Over the last 3 years at our institution, the trauma service has been utilizing the Alsius catheter and Coolguard Icy thermoregulatory system to aid in resuscitation of hypothermic patients as well as in the cooling of patients with fever and traumatic brain injury. During that same period of time, the vascular surgery service has been placing bedside inferior vena cava (IVC) fi lters in critically ill patients using intravascular ultrasound (IVUS) (4, 5) . Some of the patients who had TRCs used during their hospital course also had IVC fi lters placed either for prophylaxis or after a 
diagnosis of deep venous thrombosis (DVT) or pulmonary embolus (PE)
. Surprisingly, caval thrombus was found in several of these patients undergoing placement of an IVC fi lter with IVUS. Currently, only one series has examined the risk of iliofemoral DVT (6) , and only one case has been reported of vena cava thrombus associated with the use of a TRC (7). We performed a retrospective review to examine whether trauma patients who have been exposed to a TRC are at additional risk for iliocaval DVT in addition to the risk of DVT associated with femoral vein catheterization.
MATERIALS AND METHODS
Institutional review board approval was obtained for our study. Patient records were obtained from the trauma registry at Baylor University Medical Center at Dallas to identify patients who had TRCs placed beginning in 2008. Catheterization lab records were reviewed to identify patients receiving IVC fi lters during the same time period. Th e Student's t test was used for statistical comparison of age and injury severity score (ISS).
RESULTS
Since 2008, 83 trauma patients have had a TRC placed as part of their postinjury care: 47 of those patients, with an average age of 41 years and an ISS of 20.9, survived their initial injuries, and 32 patients had no diagnosis of DVT/PE, nor were they selected for prophylactic IVC fi lter placement. Fifteen of the 47 were referred for IVC fi lter placement. Five of these 15 patients were diagnosed with either DVT or PE prior to vascular referral. Four patients received an IVC fi lter; of them, three underwent fi lter placement under fl uoroscopy, and the other patient who received a fi lter secondary to PE had it placed with IVUS guidance. Th is demonstrated a caval thrombus. Th e fi fth patient was found to have a femoral DVT and was treated with anticoagulation.
Ten patients underwent prophylactic placement or attempted placement of an IVC fi lter at bedside with IVUS, four of whom were discovered to have IVC thrombus at the time of fi lter placement. A fi fth patient was diagnosed with caval thrombus by IVUS, but had too extensive a thrombus to allow for IVC fi lter placement. He was treated with anticoagulation. Th e remaining fi ve patients did not have caval thrombus detected by IVUS (Figure 1) . Th e average age for patients with DVT, PE, or vena cava thrombus was 28 years. Th is was less than the average age of the overall group (41) but was not statistically diff erent (P > 0.05). Th e ISS of the patients in the DVT, PE, or vena cava thrombus subgroup was 33. Th is was much higher than in the overall group (ISS = 21) treated with TRCs who survived their initial injuries, and this diff erence reached statistical signifi cance (P = 0.039).
DISCUSSION
TRCs have been shown to be an eff ective clinical tool, whether to improve outcomes when used for corporal cooling after cardiac arrest or to effi ciently reverse hypothermia (1-3). However, there is little reported evidence addressing potential complications. Specifi cally, the potential to form venous thromboembolism (VTE) has only been reported in one study (6) and in a single case report (7) .
Th e patient population examined in this study was at high risk for DVT/VTE. Because of their associated injuries, most of these patients could not receive chemical DVT prophylaxis. Critical illness with contraindications to chemoprophylaxis carries a 7% DVT risk (8) . DVT/VTE associated with femoral vein catheters ranges from 10% to 25% (9, 10) . In looking at our institutional experience with TRCs by the trauma service, we found that the overall rate of DVT/VTE formation was 21% (10/47). Th is is at the high end of the spectrum, but not out of line with what has been previously published. A previous study of DVT formation in patients with TRCs showed a 50% rate of DVT formation (6) .
We found occult caval thrombus in 60% of patients ultimately diagnosed with DVT. Given the high incidence of occult caval DVT discovered at the time of prophylactic fi lter placement, we feel that the 21.3% rate of DVT (specifi cally caval DVT) in this study may be an underestimation. Only 10 of 47 patients underwent cavography or IVUS. Th e status of the IVC was not evaluated in 32 of the 47 patients in this series, and a signifi cant number of caval DVT cases could have gone undetected.
We did fi nd a higher ISS in patients with DVT/PE (33 vs. 21, P = 0.039) compared to the overall group. Th is could indicate that injury severity contributes to DVT formation. However, we feel that this possibly represents a selection bias, as the more critically ill patients are typically selected to receive prophylactic IVC fi lters. Only by studying every patient receiving a TRC can the true rate of DVT and caval DVT be determined and the eff ect of age and ISS be honestly assessed.
Th ere are two points of concern regarding the DVT/VTE associated with these catheters. Th e fi rst is the fact that half of the caval DVTs were found in asymptomatic patients. Th erefore, the actual rate of DVT formation could be as high as 50% in our studied patient population (similar to the experience of Simosa et al). Since 60% of patients having prophylactic IVC fi lters placed were found to have IVC DVT, the use of TRCs may increase the incidence of DVT signifi cantly higher than the baseline rates for critically ill patients who typically develop DVT in the lower extremity veins or in the femoral vein if a catheter has been placed there. Th e second point of concern is Thermoregulatory catheter-associated inferior vena cava thrombus April 2013that these proximal DVTs are much more dangerous, as they are associated with a higher mortality rate when compared with more distal DVTs (11) . Th ey are also less likely to be detected by surveillance, symptoms, or noninvasive imaging. Th e increased incidence of caval DVT with TRCs identifi ed by our study is therefore quite worrisome.
Although there has not been a comparison of IVUS and venography for thrombotic occlusion, IVUS has been shown to be more sensitive than venography in detecting nonthrombotic lesions (12, 13) . Th is increased sensitivity may translate to the diagnosis of thrombotic lesions as well. Caval DVT in patients from TRCs can be nonocclusive and attached to the wall of the IVC and may not be obvious on venography. However, IVUS readily identifi es these clots (Figure 2) . Notably, the three patients in our series who had fl uoroscopy only when having their IVC fi lters placed could have had missed caval thrombus. We believe that the use of IVUS during the placement of IVC fi lters increased the sensitivity in identifying occult caval DVTs in asymptomatic patients. Th erefore, we recommend the use of IVUS to detect occult DVT in patients with a history of femoral TRCs.
